Publication | Open Access

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

EpidemiologyRespiratory DiseasesMedicineRespiratory InfectionInfectious Respiratory DiseaseAdaptive Platform TrialPulmonary DiseaseCovid-19High Risk